Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume

Stroke

Volumn 35, Issue 10, 2004, Pages 2390-2395

  Vendrame, Martina ^a   Cassady, Jordan ^a   Newcomb, Jennifer ^a   Butler, Tanya ^a   Pennypacker, Keith R ^a   Zigova, Tanja ^a   Sanberg, Cyndy Davis ^b   Sanberg, Paul R ^a   Willing, Alison E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Saneron CCEL Therapeutics Inc   (United States)

Author keywords

Acute stroke; Cell transplantation; Neuroprotection

Indexed keywords

GLYCEROL 3 PHOSPHATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN INFARCTION SIZE; BRAIN REGION; CELL NUCLEUS; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOFLUORESCENCE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPLEEN; UMBILICAL CORD BLOOD;

ANIMALS; BRAIN; CEREBROVASCULAR ACCIDENT; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 4744341332     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000141681.06735.9b     Document Type: Article

References (26)

1. Studer L, Tabar V, McKay RD. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci. 1998;1:290-295.
2. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol. 2002;20:1103-1110.
3. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164:247-256.
4. Bicknese AR, Goodwin HS, Quinn CO, Henderson VC, Chien SN, Wall DA. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant. 2002;11:261-264.
5. Padovan CS, Jahn K, Birnbaum T, Reich P, Sostak P, Strupp M, Straube A. Expression of neuronal markers in differentiated marrow stromal cells and cd133+ stem-like cells. Cell Transplant. 2003;12:839-848.
6. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682-2688.
7. Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. Human umbilical cord blood stem cells infusion in spinal cord injury: Engraftment and beneficial influence on behavior. J Hematother Stem Cell Res. 2003;12:271-278.
8. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296-307.
9. Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, Chopp M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002;11:275-281.
10. Lewis ID. Clinical and experimental uses of umbilical cord blood. Intern Med J. 2002;32:601-609.
11. Willing AE, Vendrame M, Mallery J, Cassady CJ, Davis CD, Sanchez-Ramos J, Sanberg PR. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 2003;12:449-454.
12. Borlongan CV, Stahl CE, Fujisaki T, Sanberg PR, Watanabe S. Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotropism, or both? Cell Transplant. 1999;8:153-159.
13. Persson L, Hardemark HG, Bolander HG, Hillered L, Olsson Y. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke. 1989;20:641-645.
14. Steele A, Jones OY, Gok F, Steele P, Chamizo W, Good RA. Detection of green fluorescent protein-tagged donor cells in BXSB mice treated with total myeloablative bone marrow transplantation using a rapid autofluorescent occlusion method in paraffin-embedded tissue. Stem Cells. 2004; In press.
15. Obana WG, Pitts LH, Nishimura MC. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat. J Neurosurg. 1988;69:98-103.
16. Grotta JC, Pettigrew LC, Rosenbaum D, Reid C, Rhoades H, McCandless D. Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke. 1988;19:447-454.
17. Newman M, Willing A, Cassady CJ, Manresa JJ, Kedziorek DA, Davis C, Saporta S, Sanberg PR. In vitro migration and phenotype identification of human umbilical cord blood (HUCB) cells to stroke brain. Experimental Neurology. 2003;181:84-112 (abstract).
18. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002;59:514-523.
19. Mahmood A, Lu D, Lu M, Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery. 2003;53:697-702, discussion 702-703.
20. Sorg RV, Andres S, Kogler G, Fischer J, Wernet P. Phenotypic and functional comparison of monocytes from cord blood and granulocyte colony-stimulating factor-mobilized apheresis products. Exp Hematol. 2001;29:1289-1294.
21. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: A role for lymphocytes in ischemic brain injury? Stroke. 2003;34:1809-1815.
22. Pomyje J, Zivny J, Sefc L, Plasilova M, Pytlik R, Necas E. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur J Haematol. 2003;70:143-150.
23. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, Del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;4:2.
24. Rainsford E, Reen DJ. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol. 2002;116:702-709.
25. Bracci-Laudiero L, Celestino D, Starace G, Antonelli A, Lambiase A, Procoli A, Rumi C, Lai M, Picardi A, Ballatore G, Bonini S, Aloe L. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor trkA. J Neuroimmunol. 2003;136:130-139.
26. Borlongan CV, Hadman M, Davis Sanberg C, Sanberg PR. CNS entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004;35:2385-2389.